Cargando…

Repurposing mucosal delivery devices for live attenuated tuberculosis vaccines

Tuberculosis (TB) remains one of the most lethal infectious diseases globally. The only TB vaccine approved by the World Health Organization, Bacille Calmette-Guérin (BCG), protects children against severe and disseminated TB but provides limited protection against pulmonary TB in adults. Although s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puri, Munish, Miranda-Hernandez, Socorro, Subbian, Selvakumar, Kupz, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098179/ https://www.ncbi.nlm.nih.gov/pubmed/37063870 http://dx.doi.org/10.3389/fimmu.2023.1159084

Ejemplares similares

Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis
por: Flores-Valdez, Mario Alberto, et al.
Publicado: (2022)

Immunometabolism in Tuberculosis
por: Shi, Lanbo, et al.
Publicado: (2016)

Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections
por: Seo, Sang-Uk, et al.
Publicado: (2022)

Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2015)

GM-CSF Dependent Differential Control of Mycobacterium tuberculosis Infection in Human and Mouse Macrophages: Is Macrophage Source of GM-CSF Critical to Tuberculosis Immunity?
por: Mishra, Abhishek, et al.
Publicado: (2020)

Repurposing Immunomodulatory Drugs to Combat Tuberculosis
por: Fatima, Samreen, et al.
Publicado: (2021)

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis
por: Subbian, Selvakumar, et al.
Publicado: (2016)

BCG Vaccination Prevents Reactivation of Latent Lymphatic Murine Tuberculosis Independently of CD4(+) T Cells
por: Sathkumara, Harindra D., et al.
Publicado: (2019)

Human Macrophages Exhibit GM-CSF Dependent Restriction of Mycobacterium tuberculosis Infection via Regulating Their Self-Survival, Differentiation and Metabolism
por: Mishra, Abhishek, et al.
Publicado: (2022)

Development of Endotoxin Tolerance Does Not Influence the Response to a Challenge with the Mucosal Live-Attenuated Influenza Vaccine in Humans In Vivo
por: Koch, Rebecca M., et al.
Publicado: (2017)

Host-Directed Therapeutic Strategies for Tuberculosis
por: Kolloli, Afsal, et al.
Publicado: (2017)

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis
por: Teskey, Garrett, et al.
Publicado: (2018)

Live-Attenuated Bacterial Vectors for Delivery of Mucosal Vaccines, DNA Vaccines, and Cancer Immunotherapy
por: Kumar, Sudeep
Publicado: (2019)

Harnessing the mTOR Pathway for Tuberculosis Treatment
por: Singh, Pooja, et al.
Publicado: (2018)

A Systematic Review: The Role of Resident Memory T Cells in Infectious Diseases and Their Relevance for Vaccine Development
por: Muruganandah, Visai, et al.
Publicado: (2018)

Corticosteroids for COVID-19 Therapy: Potential Implications on Tuberculosis
por: Gopalaswamy, Radha, et al.
Publicado: (2021)

Editorial: Mucosal Vaccination: Strategies to Induce and Evaluate Mucosal Immunity
por: Kozlowski, Pamela A., et al.
Publicado: (2022)

Repurposing Saquinavir for Host-Directed Therapy to Control Mycobacterium Tuberculosis Infection
por: Pires, David, et al.
Publicado: (2021)

Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin
por: Copland, Alastair, et al.
Publicado: (2018)

The Rise of Non-Tuberculosis Mycobacterial Lung Disease
por: Ratnatunga, Champa N., et al.
Publicado: (2020)

An improved protocol to establish experimental tuberculous meningitis in the rabbit
por: O'Brien, Paul, et al.
Publicado: (2020)

Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis
por: Perdomo, Carolina, et al.
Publicado: (2016)

Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection
por: Corthésy, Blaise, et al.
Publicado: (2018)

Chrysanthemum sporopollenin: A novel vaccine delivery system for nasal mucosal immunity
por: Liu, Jun, et al.
Publicado: (2023)

A phosphodiesterase-4 inhibitor reduces lung inflammation and fibrosis in a hamster model of SARS-CoV-2 infection
por: Kolloli, Afsal, et al.
Publicado: (2023)

Editorial: Host-Directed Therapies for Tuberculosis
por: Costa, Diego L., et al.
Publicado: (2021)

In vitro Intestinal Mucosal Epithelial Responses to Wild-Type Salmonella Typhi and Attenuated Typhoid Vaccines
por: Fiorentino, Maria, et al.
Publicado: (2013)

High-Resolution Quantitative Mapping of Macaque Cervicovaginal Epithelial Thickness: Implications for Mucosal Vaccine Delivery
por: Vincent, Kathleen L., et al.
Publicado: (2021)

Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages
por: Koo, Mi-Sun, et al.
Publicado: (2012)

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy
por: Zhang, Yuguo, et al.
Publicado: (2022)

Current Development and Challenges of Tetravalent Live-Attenuated Dengue Vaccines
por: Hou, Jue, et al.
Publicado: (2022)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

Liposomal Delivery of the RNA Genome of a Live-Attenuated Chikungunya Virus Vaccine Candidate Provides Local, but Not Systemic Protection After One Dose
por: Abeyratne, Eranga, et al.
Publicado: (2020)

What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen‐presenting cell function in the lower respiratory tract
por: Pai, Saparna, et al.
Publicado: (2020)

Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ
por: Tran, Andy C., et al.
Publicado: (2020)

Modulation of systemic and mucosal immunity against an inactivated vaccine of Newcastle disease virus by oral co-administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interleukin-18 and interferon-α
por: RAHMAN, Md. Masudur, et al.
Publicado: (2014)

Systemic and Mucosal B and T Cell Responses Upon Mucosal Vaccination of Teleost Fish
por: Muñoz-Atienza, Estefanía, et al.
Publicado: (2021)

Of tuberculosis and non-tuberculous mycobacterial infections – a comparative analysis of epidemiology, diagnosis and treatment
por: Gopalaswamy, Radha, et al.
Publicado: (2020)

Immunomodulation resulting of helminth infection could be an opportunity for immunization against tuberculosis and mucosal pathogens
por: Chin, Kai Ling, et al.
Publicado: (2023)

Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection
por: Kolloli, Afsal, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1atts265em6aob7e12tnceoq62